[1]
“Elotuzumab in multiple myeloma: a single centre experience”, Eur J Oncol, vol. 23, no. 2, pp. 72–79, Dec. 2018, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/7498